Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 43.94 K228.97 K258.22 K225.55 K226.56 K160.98 K 871.3 K Research & development —————— — Operating income -43.94 K-228.97 K-258.22 K-225.55 K-226.56 K-160.98 K -871.3 K Non-Operating Income, Total 02.81 M3.26 M2.97 M2.72 M2.75 M 11.7 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 01.4 M3.26 M2.97 M2.72 M2.75 M 11.7 M Unusual income/expense 01.4 M———— — Pretax income -43.94 K2.58 M3 M2.75 M2.49 M2.59 M 10.83 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -43.94 K1.17 M3 M2.75 M2.49 M2.59 M 10.83 M Discontinued operations —————— — Net income -43.94 K1.17 M3 M2.75 M2.49 M2.59 M 10.83 M Dilution adjustment ——3.26 M—2.72 M2.75 M — Preferred dividends ——3.26 M—2.72 M2.75 M — Diluted net income available to common stockholders -43.94 K1.17 M3 M2.75 M2.49 M2.59 M 10.83 M Basic earnings per share (Basic EPS) 0.020.060.080.10.070.07 0.32 Diluted earnings per share (Diluted EPS) 0.030.050.080.10.070.07 0.32 Average basic shares outstanding -22.97 M7.5 M15.47 M19.27 M30.02 M30.02 M — Diluted shares outstanding -22.97 M7.5 M15.47 M19.27 M30.02 M30.02 M — EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —